Boris Blechacz

Parvovirus vectors: use and optimisation in cancer gene therapy.

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.

Cholangiocarcinoma.

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Tumor-specific marker genes for intrahepatic cholangiocarcinoma: utility and mechanistic insight.

Images in clinical medicine. Severe kyphosis.

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis.

A conceptual proposal for staging ductal cholangiocarcinoma.

Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.

A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells.

A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells.

Positron emission tomography scan for a hepatic mass.

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.

Clinical diagnosis and staging of cholangiocarcinoma.

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

Hepatocellular carcinoma biology.

Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection.

Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population.

Biopsy for liver cancer: How to balance research needs with evidence-based clinical practice.

HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.

Cancer review: Cholangiocarcinoma.

Natural language processing as an alternative to manual reporting of colonoscopy quality metrics.

A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.

Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center.

Loss of the TGF-β Effector β2SP Promotes Genomic Instability.

Cholangiocarcinoma: Current Knowledge and New Developments.

Loss of the transforming growth factor-β effector β2-Spectrin promotes genomic instability.

A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults.